- Top 30 Oncology Drugs Manufacturers 2019
- AstraZeneca, Merck, Novartis, Amgen, GlaxoSmithKline, Johnson & Johnson, Roche, Pfizer, Eli Lilly, Other Companies
LONDON, July 5, 2019 /PRNewswire/ -- Cancer treating drugs market forms the most lucrative sector in pharmaceuticals. As the ageing population continues to rise across the world, the incidence of cancer will continue to grow, leading to increased spending on cancer-treating medicines. This report lists and discusses the top 30 oncology drugs manufacturers.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 157-page report you will receive 83 tables and 64 figures–all unavailable elsewhere.
The 157-page report provides clear detailed insight into the top 30 oncology drugs manufacturers. Discover the key drivers and challenges affecting the market.
By ordering and reading Visiongain's brand-new report today you stay better informed and ready to act.
To request sample pages from this report please contact Sara Peerun at email@example.com or refer to our website: https://www.visiongain.com/report/top-30-oncology-drugs-manufacturers-2019/#download_sampe_div
• Assessment of the leading companies in the global oncology drugs market. The list below shows some of the companies that are discussed in the report:
• Abbott Laboratories
• Astellas Pharma
• Aurora Biophama
• Boehringer Ingelheim
• Bristol-Myers Squibb (BMS)
• Celgene Corporation
• Eli Lilly
• Fresenius Kabi
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Jounce Therapeutics
• Other companies
• For each company, the report provides information and discussion on:
• Company overview
• Product portfolio
• Recent development
• Financial information
• Key questions answered by this report:
• How is the Oncology Drugs Manufacturers market evolving?
• What is driving and restraining the Oncology Drugs Manufacturers market?
• What will be the main driver for the overall market?
• Will leading Oncology Drugs Manufacturers broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• Who are the leading players and what are their prospects over the forecast period?
To request a report overview of this report please contact Sara Peerun at firstname.lastname@example.org or refer to our website: https://www.visiongain.com/report/top-30-oncology-drugs-manufacturers-2019/
Did you know that we also offer a report add-on service? Email email@example.com to discuss any customized research needs you may have.
Companies covered in the report include:
Abbott Laboratories, Inc.
Agios Pharmaceuticals, Inc.
Allogene Therapeutics, Inc.
ARMO BioSciences, Inc.
Astellas Pharma Inc.
AurKa Pharma, Inc.
Aurora Biopharma, Inc.
Celgene International Sarl
Eisai Co., Ltd.
Flexus Biosciences, Inc.
Foundation Medicine, Inc.
Fresenius Kabi AG
Genscript Biotech Corporation
Janssen Diagnostics, LLC.
Johnson & Johnson
Jounce Therapeutics, Inc.
Juno Therapeutics, Inc.
Legend Biotech Ireland Limited
Legend Biotech USA Inc.
Menarini Industrie Farmaceutiche Riunite Srl
Merck & Co.
Ono Pharmaceutical Company
Regeneron Pharmaceuticals, Inc
SARAH CANNON Research Institute
Sorrento Therapeutics, Inc.
Sosei Group Corporation
Sun Pharmaceutical Industries Ltd.
TerSera Therapeutics LLC
Tessa Therapeutics Pte Ltd.
Valeant Phamaceuticals International, Inc.
ZIOPHARM Oncology, Inc.
List of Organizations Mentioned in the Report
European Medicines Agency
Food and Drug Administration (FDA)
Japan's Pharmaceuticals and Medical Devices Agency (PMDA)
Japanese Ministry of Health, Labour and Welfare
World Child Cancer
World Health Organization (WHO)
To see a report overview please e-mail Sara Peerun on firstname.lastname@example.org